Study: Risk of cancer remains high for women over 50 with genetic BRCA1 or BRCA2 mutation
Medical Xpress
FEBRUARY 24, 2023
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer. Bloomberg Faculty of Nursing.
Let's personalize your content